Spire Healthcare Group (LON:SPI – Get Free Report) posted its quarterly earnings data on Wednesday. The company reported GBX (0.50) earnings per share for the quarter, Digital Look Earnings reports. Spire Healthcare Group had a return on equity of 2.22% and a net margin of 1.04%.
Spire Healthcare Group Stock Performance
SPI traded up GBX 1 on Thursday, reaching GBX 247.50. 71,514,227 shares of the stock were exchanged, compared to its average volume of 5,796,127. The company’s 50-day moving average price is GBX 238.06 and its 200 day moving average price is GBX 207.59. Spire Healthcare Group has a fifty-two week low of GBX 140.80 and a fifty-two week high of GBX 249. The company has a debt-to-equity ratio of 177.14, a current ratio of 0.63 and a quick ratio of 0.73. The firm has a market capitalization of £991.48 million, a PE ratio of 61.88, a PEG ratio of 1.06 and a beta of 0.93.
Wall Street Analyst Weigh In
Separately, Royal Bank Of Canada downgraded shares of Spire Healthcare Group to a “sector perform” rating and cut their price objective for the company from GBX 300 to GBX 250 in a report on Monday, September 7th. One research analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, Spire Healthcare Group currently has an average rating of “Moderate Buy” and a consensus target price of GBX 247.50.
About Spire Healthcare Group
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.
See Also
- Five stocks we like better than Spire Healthcare Group
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.
